Cargando…

The Mechanism of Acquired Resistance to Cisplatin by a Human Ovarian Cancer Cell Line

The present study was designed to elucidate the mechanism of resistance to cisplatin. A cisplatin‐resistant cell line (KFr) was established from KF cells derived from human serous cystadenocarcinoma of the ovary. The DNA histogram revealed an increase of S‐phase cells and a decrease of G(1)‐phase ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kikuchi, Yoshihiro, Iwano, Ichiro, Miyauchi, Munenori, Kita, Tsunekazu, Oomori, Keibun, Kizawa, Isao, Sugita, Michio, Tenjin, Yoshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1988
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917564/ https://www.ncbi.nlm.nih.gov/pubmed/3136116 http://dx.doi.org/10.1111/j.1349-7006.1988.tb00033.x

Ejemplares similares

Effects of PSK on Interleukin‐2 Production by Peripheral Lymphocytes of Patients with Advanced Ovarian Carcinoma during Chemotherapy
por: Kikuchi, Yoshihiro, et al.
Publicado: (1988)

Growth‐inhibitory Effects of N, N‐Diethyl‐2‐[4‐(phenylmethyl)phenoxy]‐ethanamine‐HCl Combined with Cisplatin on Human Ovarian Cancer Cells Inoculated into Nude Mice
por: Hiramatsu, Hisakazu, et al.
Publicado: (1997)

Altered Expression of γ‐Glutamylcysteine Synthetase, Metallothionein and Topoisomerase I or II during Acquisition of Drug Resistance to Cisplatin in Human Ovarian Cancer Cells
por: Kikuchi, Yoshihiro, et al.
Publicado: (1997)

Inhibitory Effects of Ginsenoside Rh(2) on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells
por: Nakata, Hideyuki, et al.
Publicado: (1998)

Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression
por: Bahar, Entaz, et al.
Publicado: (2020)

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
por: Zhao, Yujie, et al.
Publicado: (2021)

First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.
por: Athanassiou, A. E., et al.
Publicado: (1989)

First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence.
por: Sandercock, J., et al.
Publicado: (1998)

Cisplatin and Irinotecan as First-Line Chemotherapy for Previously Untreated Metastatic Thymic Carcinoma: Updated Analysis
por: Fukuda, Akito, et al.
Publicado: (2022)

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines
por: Donix, Lukas, et al.
Publicado: (2022)

Transcriptome profile of OVCAR3 cisplatin-resistant ovarian cancer cell line
por: Sakhare, Shruti S, et al.
Publicado: (2014)

Addition of Gallic Acid Overcomes Resistance to Cisplatin in Ovarian Cancer Cell Lines
por: Al Balushi, Najwa, et al.
Publicado: (2022)

Paclitaxel and SN‐38 Overcome Cisplatin Resistance of Ovarian Cancer Cell Lines by Down‐regulating the Influx and Efflux System of Cisplatin
por: Komuro, Yuuki, et al.
Publicado: (2001)

Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines
por: Engblom, P, et al.
Publicado: (1999)

Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines.
por: McClay, E. F., et al.
Publicado: (1994)

Cisplatin Resistant Patterns in Ovarian Cell Line Using FTIR and Principle Component Analysis
por: Zendehdel, Rezvan, et al.
Publicado: (2012)

Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines
por: Baribeau, Sébastien, et al.
Publicado: (2014)

Long-term Effect of Smoking on Serum Pepsinogen Values
por: Kikuchi, Shogo, et al.
Publicado: (2007)

Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines
por: Heiserman, James Patrick, et al.
Publicado: (2023)

Resistance to caspase-8 and -9 fragments in a malignant pleural mesothelioma cell line with acquired cisplatin-resistance
por: Janson, V, et al.
Publicado: (2010)

Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.
por: Ottone, F., et al.
Publicado: (1997)

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
por: Freeburg, Elizabeth M, et al.
Publicado: (2009)

Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein
por: Stordal, Britta, et al.
Publicado: (2012)

Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2017)

The timing of caffeic acid treatment with cisplatin determines sensitization or resistance of ovarian carcinoma cell lines
por: Sirota, R., et al.
Publicado: (2016)

Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell Line
por: Fujiwara, Yasuhiro, et al.
Publicado: (1990)

In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
por: Mellish, K. J., et al.
Publicado: (1993)

Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study
por: Ratzon, Einav, et al.
Publicado: (2016)

Cisplatin induces stemness in ovarian cancer
por: Wiechert, Andrew, et al.
Publicado: (2016)

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
por: Moorsel, C J A van, et al.
Publicado: (1999)

Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines
por: Okuno, S, et al.
Publicado: (2003)

The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines
por: Kim, Min-Gyun, et al.
Publicado: (2012)

Efficacy of cisplatin combined with vinorelbine as second- or higher-line palliative chemotherapy in patients with advanced ovarian cancer
por: Yeon, Sang Hoon, et al.
Publicado: (2023)

Identification of genes differentially expressed in association with acquired cisplatin resistance
por: Johnsson, A, et al.
Publicado: (2000)

Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines
por: Noordhuis, Paul, et al.
Publicado: (2019)

Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.
por: Loh, S. Y., et al.
Publicado: (1992)

Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
por: Sharp, S. Y., et al.
Publicado: (1994)

Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780
por: Engelke, Laura H., et al.
Publicado: (2016)

New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines
por: Świerczewska, Monika, et al.
Publicado: (2017)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l1adbl6ctbklm31pcthf3ogrj9